980 results
Treatment for calcified coronary artery disease in the real world
19 May 2026 – From EuroPCR 2026
This session presents real-world experiences and evidence on treating calcified coronary artery disease. It includes meta-analyses comparing rotational atherectomy and balloon angioplasty, long-term outcomes of excimer laser atherectomy, and multicenter registry data on intravascular lithotripsy (IVL), particularly in diabetic and high-risk patients. The session also focuses...
Rapid fire session on vascular innovation, interventional technologies and hypertension
18 May 2026 – From EuroPCR 2026
This rapid fire session showcased cutting-edge innovations in vascular interventions, interventional technologies, and hypertension management. Highlights included three-dimensional OCT-guided ultrafast laser atherectomy for calcified lesions, a novel biodegradable metallic stent, intelligent pressure-controlled perfusion to prevent acute limb ischemia, a microneedle balloon catheter, personalized arterial hypertension control...
What is the future of intracoronary imaging for assessment of calcified lesions?
21 May 2026 – From EuroPCR 2026
In this conversation, Angela McInerney and Ziad Ali explore the evolving role of imaging in calcified coronary artery disease, the growing evidence supporting intracoronary imaging, particularly OCT and IVUS, and how detailed plaque characterisation and scoring systems can improve procedural planning and outcomes. Looking ahead, they...
Risk evaluation in asymptomatic patients: what is the current and future role of CT angiography?
21 May 2026 – From EuroPCR 2026
Ronak Rajani and Carlos Collet discuss the role of coronary CT angiography in cardiovascular risk assessment among asymptomatic individuals. They review current approaches to risk stratification and examine whether imaging can provide incremental value beyond traditional clinical risk factors.
The conversation explores the growing range of information available...
Why are most unstable coronary lesions missed by angiography?
20 May 2026 – From EuroPCR 2026
Inflammation is increasingly recognised as a key driver of residual cardiovascular risk and plaque instability in coronary artery disease. Yet many vulnerable plaques remain difficult to identify using conventional angiography, often appearing as non-obstructive lesions despite their potential to cause acute coronary events.
In this interview, Davide...
What is the latest in the management of coronary artery disease in TAVI candidates?
20 May 2026 – From EuroPCR 2026
Ole De Backer and Daniel Blackman discuss the management of coronary artery disease in TAVI candidates and whether PCI should be performed before valve implantation or safely deferred.
They review PROTAVI, which supports a selective strategy with PCI only when clinically indicated, with a signal toward less...
Reducing radiation exposure in the cath lab: What you need to know
20 May 2026 – From EuroPCR 2026
In this discussion, Angeliki Kolyda and Shareefah Shereef highlight the importance of reducing radiation exposure in the cath lab for both patients and staff. They emphasise the cumulative risks of repeated low-dose exposure and the need to adhere to the ALARA principle: minimising radiation through careful...
What is the role of AI in the cath lab of tomorrow?
20 May 2026 – From EuroPCR 2026
Louis‑Marie Desroche and Joost Daemen explore the growing role of artificial intelligence in interventional cardiology. From risk stratification and CT-based plaque analysis to intracoronary imaging and angiography-derived physiology, AI is already transforming decision-making before and during PCI. Looking ahead, they highlight AI’s potential to become a...
How are the FRACTURE IDE trial results on laser-based intravascular lithotripsy going to impact the management of calcified lesions?
19 May 2026 – From EuroPCR 2026
Evald Christiansen and Margaret McEntegart review the results of the FRACTURE IDE trial which evaluated a novel optical laser-based intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary lesions. The study demonstrated high rates of procedural success and safety, with low rates of clinically...
How to best identify and manage vulnerable plaque?
19 May 2026 – From EuroPCR 2026
Hector Garcia-Garcia joins Salvatore Brugaletta in a discussion on the concept of vulnerable plaque, a key topic in contemporary cardiology. Together, they review the well-established definition of vulnerable plaque, characterised by high-risk features that predispose to rupture and cardiovascular events, and explore how advances in invasive and...
